0.263 -0.01 (-3.63%) | 04-25 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 0.37 | 1-year : | 0.44 |
Resists | First : | 0.32 | Second : | 0.37 |
Pivot price | 0.29 | |||
Supports | First : | 0.23 | Second : | 0.19 |
MAs | MA(5) : | 0.27 | MA(20) : | 0.28 |
MA(100) : | 0.36 | MA(250) : | 0.88 | |
MACD | MACD : | -0.1 | Signal : | -0.1 |
%K %D | K(14,3) : | 36.3 | D(3) : | 39.7 |
RSI | RSI(14): 39.9 | |||
52-week | High : | 2.45 | Low : | 0.2 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ RBOT ] has closed above bottom band by 16.3%. Bollinger Bands are 45.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 0.27 - 0.28 | 0.28 - 0.28 |
Low: | 0.25 - 0.25 | 0.25 - 0.25 |
Close: | 0.26 - 0.26 | 0.26 - 0.27 |
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Mon, 22 Apr 2024
Vicarious Surgical (RBOT) to Release Quarterly Earnings on Monday - MarketBeat
Mon, 08 Apr 2024
Vicarious Surgical to Report First Quarter 2024 Financial Results on April 29, 2024 - Yahoo Finance
Tue, 05 Mar 2024
Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth? - Simply Wall St
Tue, 05 Mar 2024
A New Cause for Concern: Vicarious Surgical Inc. Adds a New Share Price & Shareholder Rights Risk - TipRanks.com - TipRanks
Tue, 05 Mar 2024
Vicarious Surgical Inc. (NYSE:RBOT) Q4 2023 Earnings Call Transcript - Yahoo Finance
Tue, 05 Mar 2024
Vicarious Surgical expects to submit surgical robot to FDA in 2026 - Mass Device
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
NYSE
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Devices
|
|
Shares Out | 156 (M) |
Shares Float | 84 (M) |
Held by Insiders | 31.5 (%) |
Held by Institutions | 42.7 (%) |
Shares Short | 6,100 (K) |
Shares Short P.Month | 5,180 (K) |
EPS | -0.5 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0.56 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | -38.5 % |
Return on Equity (ttm) | -68.1 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | -0.51 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -62 (M) |
Levered Free Cash Flow | -36 (M) |
PE Ratio | -0.54 |
PEG Ratio | 0 |
Price to Book value | 0.46 |
Price to Sales | 0 |
Price to Cash Flow | -0.66 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |